Literature DB >> 20375642

[The relationship between hepatitis B virus infection and the incidence of pancreatic cancer: a retrospective case-control study].

Seung Goun Hong1, Ji Hoon Kim, Young Sun Lee, Eileen Yoon, Hyun Jung Lee, Jin Ki Hwang, Eun Suk Jung, Moon Kyung Joo, Young Kul Jung, Jong Eun Yeon, Jong Jae Park, Jae Seon Kim, Young Tae Bak, Kwan Soo Byun.   

Abstract

BACKGROUND/AIMS: An association between past history of hepatitis B virus (HBV) infection and pancreatic cancer (PC) has recently been reported. We investigated whether HBV and hepatitis C virus (HCV) infections are associated with the development of PC in Korea.
METHODS: We retrospectively recruited patients with PC and sex- and, age-matched control patients with stomach cancer (SC) during the previous 5 years. Serum HBsAg and anti-HCV were examined, and data on smoking, alcohol intake, diabetes, and the history of chronic pancreatitis (CP) were collected.
RESULTS: A total of 506 PC and 1008 SC were enrolled, with respectively 58.1% and 97.3% of these cases being confirmed histologically. The mean age and sex ratio (male:female) were 63.5 years and 1.5:1 in the PC patients and 63.9 years and 1.5:1 in the SC patients respectively (P>0.05). The odds ratios (95% confidence interval, 95% CI) in univariate analysis were 0.90 (0.52-1.56; P=0.70) for HBsAg, 1.87 (0.87-4.01; P=0.11) for anti-HCV, 2.66 (2.04-3.48; P<0.001) for the presence of diabetes, 2.30 (1.83-2.90; P<0.001) for smoking, 1.14 (0.89-1.46; P=0.31) for alcohol intake, and 4.40 (1.66-11.66; P=0.003) for the history of CP. Independent risk factors for PC were presence of diabetes (OR, 2.67; 95% CI, 2.00-3.56; P<0.001), smoking (OR, 2.49; 95% CI, 1.93-3.21; P<0.001) and history of CP (OR, 4.60; 95% CI, 1.56-13.53; P=0.006).
CONCLUSIONS: There was no significant association between seropositivity for HBsAg or anti-HCV and PC. Further studies are warranted to clarify the association between HBV infection and PC in regions where HBV is endemic.

Entities:  

Mesh:

Year:  2010        PMID: 20375642     DOI: 10.3350/kjhep.2010.16.1.49

Source DB:  PubMed          Journal:  Korean J Hepatol        ISSN: 1738-222X


  6 in total

1.  Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma.

Authors:  Ming-Chu Chang; Chien-Hung Chen; Ja-Der Liang; Yu-Wen Tien; Chiun Hsu; Jau-Min Wong; Yu-Ting Chang
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

Review 2.  Hepatitis B or C viral infection and risk of pancreatic cancer: a meta-analysis of observational studies.

Authors:  Jian-Hua Xu; Jin-Jian Fu; Xiao-Li Wang; Jia-Yong Zhu; Xiao-Hua Ye; Si-Dong Chen
Journal:  World J Gastroenterol       Date:  2013-07-14       Impact factor: 5.742

Review 3.  Pathogenic Microorganisms and Pancreatic Cancer.

Authors:  Chunsaie Wang; Jingna Li
Journal:  Gastrointest Tumors       Date:  2015-04-22

Review 4.  Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review.

Authors:  Sirio Fiorino; Letizia Bacchi-Reggiani; Dario de Biase; Adele Fornelli; Michele Masetti; Andrea Tura; Fabio Grizzi; Matteo Zanello; Laura Mastrangelo; Raffaele Lombardi; Giorgia Acquaviva; Luca di Tommaso; Arrigo Bondi; Michela Visani; Sergio Sabbatani; Laura Pontoriero; Carlo Fabbri; Andrea Cuppini; Annalisa Pession; Elio Jovine
Journal:  World J Gastroenterol       Date:  2015-12-07       Impact factor: 5.742

Review 5.  Microbiome-Friend or Foe of Pancreatic Cancer?

Authors:  Jaroslaw Daniluk; Urszula Daniluk; Pawel Rogalski; Andrzej Dabrowski; Agnieszka Swidnicka-Siergiejko
Journal:  J Clin Med       Date:  2021-11-29       Impact factor: 4.241

6.  Genetic variations affecting serum carcinoembryonic antigen levels and status of regional lymph nodes in patients with sporadic colorectal cancer from Southern China.

Authors:  Yu Liang; Weizhong Tang; Tiqiang Huang; Yong Gao; Aihua Tan; Xiaobo Yang; Haiying Zhang; Yanling Hu; Xue Qin; Shan Li; Shijun Zhang; Linjian Mo; Zhenjia Liang; Deyi Shi; Zhang Huang; Yingyong Guan; Jicheng Zhou; Cheryl Winkler; Stephen J O'Brien; Jianfeng Xu; Zengnan Mo; Tao Peng
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.